Helper-dependent adenoviral (HDAd) vectors are attractive for liver-directed gene therapy because they can drive sustained high levels of transgene expression without chronic toxicity. However, high vector doses are required to achieve efficient hepatic transduction by systemic delivery because of a nonlinear dose response. Unfortunately, such high doses result in systemic vector dissemination and dose-dependent acute toxicity with potential lethal consequences. We have previously shown in nonhuman primates that delivery of HDAd in surgically isolated livers resulted in a significantly higher hepatic transduction with reduced systemic vector dissemination compared with intravenous delivery and multiyear transgene expression. Encouraged by these data, we have now employed a surgical vector delivery method in the Gunn rat, an animal model for Crigler-Najjar syndrome. After vector delivery into the surgically isolated liver, we show phenotypic correction at the low and clinically relevant vector dose of 1×1011 vp/kg. Correction of hyperbilirubinemia and increased glucuronidation of bilirubin in bile was achieved for up to 1 year after vector administration. Surgical delivery of the vector was well tolerated without signs of acute or chronic toxicity. This method of delivery could thereby be a safer alternative to liver transplantation for long-term treatment of Crigler-Najjar syndrome type I.

Correction of hyperbilirubinemia in Gunn rats by surgical delivery of low doses of HDAd vectors / Schmitt, F; Pastore, N; Abarrategui Pontes, C; Flageul, M; Myara, A; Laplanche, S; Labrune, P; Podevin, G; Nguyen, T; BRUNETTI PIERRI, Nicola. - In: HUMAN GENE THERAPY. PART B. METHODS. - ISSN 1946-6536. - 25:3(2014), pp. 181-186. [10.1089/hgtb.2013.236]

Correction of hyperbilirubinemia in Gunn rats by surgical delivery of low doses of HDAd vectors.

Pastore N;BRUNETTI PIERRI, NICOLA
2014

Abstract

Helper-dependent adenoviral (HDAd) vectors are attractive for liver-directed gene therapy because they can drive sustained high levels of transgene expression without chronic toxicity. However, high vector doses are required to achieve efficient hepatic transduction by systemic delivery because of a nonlinear dose response. Unfortunately, such high doses result in systemic vector dissemination and dose-dependent acute toxicity with potential lethal consequences. We have previously shown in nonhuman primates that delivery of HDAd in surgically isolated livers resulted in a significantly higher hepatic transduction with reduced systemic vector dissemination compared with intravenous delivery and multiyear transgene expression. Encouraged by these data, we have now employed a surgical vector delivery method in the Gunn rat, an animal model for Crigler-Najjar syndrome. After vector delivery into the surgically isolated liver, we show phenotypic correction at the low and clinically relevant vector dose of 1×1011 vp/kg. Correction of hyperbilirubinemia and increased glucuronidation of bilirubin in bile was achieved for up to 1 year after vector administration. Surgical delivery of the vector was well tolerated without signs of acute or chronic toxicity. This method of delivery could thereby be a safer alternative to liver transplantation for long-term treatment of Crigler-Najjar syndrome type I.
2014
Correction of hyperbilirubinemia in Gunn rats by surgical delivery of low doses of HDAd vectors / Schmitt, F; Pastore, N; Abarrategui Pontes, C; Flageul, M; Myara, A; Laplanche, S; Labrune, P; Podevin, G; Nguyen, T; BRUNETTI PIERRI, Nicola. - In: HUMAN GENE THERAPY. PART B. METHODS. - ISSN 1946-6536. - 25:3(2014), pp. 181-186. [10.1089/hgtb.2013.236]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/609680
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 11
social impact